Lunai Bioworks Inc.
LNAICIK 0001527728 · Pharmaceutical Preparations · Nasdaq
- RENOVARO INC. (until 2025-08-26)
- RENOVARO BIOSCIENCES INC. (until 2024-02-07)
- Enochian Biosciences Inc (until 2023-08-01)
- DanDrit Biotech USA, Inc. (until 2018-02-23)
- Putnam Hills Corp. (until 2014-02-11)
Revenue (TTM)
$95.95K
Q3 May 2026
Net Income (TTM)
−$1.36M
−101.3% YoY
Q3 May 2026
EPS Diluted (TTM)
−$0.05
−18.7% YoY
Q3 May 2026
Gross Margin
-58.9%
Q3 May 2026
Operating Margin
-11,226.2%
Q3 May 2026
Net Margin
-1,420.1%
Q3 May 2026
Free Cash Flow (TTM)
−$9.18M
Q3 May 2026
Cash
$3.16M
Q3 May 2026
Total Debt
$223.18K
Q3 May 2026
Shares Outstanding
36.27M sh
Q3 May 2026
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.